Adjuvant effect of anti-idiotypic antibodies to Yersinia pestis lipopolysaccharide

Journal of Medical Microbiology

Volumn 48, Issue 8, 1999, Pages 751-756

  Feodorova, V A ^a   Devdariani, Z L ^a   Nazarova, L S ^a  

^a RUSSIAN RESEARCH ANTI PLAGUE INSTITUTE MICROBE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; PARAPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; YERSINIA PESTIS;

EID: 0032885161     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-8-751     Document Type: Article

References (36)

1. 1. Williams JE, Arntzen L, Tyndal GL, Isaäcson M. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia, 1982. Bull World Health Organ 1986; 64: 745-752.
2. 2. Meyer KF, Hightower JA, McCrumb FR. Plague immunization. VI. Vaccination with the fraction 1 antigen of Yersinia pestis. J Infect Dis 1974; 129: S41-S45.
3. 3. Simpson WJ, Thomas RE, Schwan TG. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in Balb/c mice. Am J Trop Med Hyg 1990; 43: 389-396.
4. 4. Williamson ED, Eley SM, Griffin KF et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol 1995; 12: 223-230.
5. 5. Drozdov IG, Anisimov AP, Samoilova SV et al. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J Med Microbiol 1995; 42: 264-268.
6. 6. Perry RD, Fetherston JD. Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 1997; 10: 35-66.
7. 7. Andrews GP, Heath DG, Anderson GW, Welkos SL, Friedlander AM. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 1996; 64: 2180-2187.
8. 8. Allison AC, Byars NE. Immunological adjuvants: desirable properties and side-effects. Mol Immunol 1991; 28: 279-284.
9. 9. Baldwin CL, Winter AJ. Blastogenic response of bovine lymphocytes to Brucella abortus lipopolysaccharide. Infect Immun 1985; 47: 570-572.
10. 10. Coleman DK, Culver KE, Ryan JL. Effect of lipopolysaccharide on the stimulation of macrophage Fc-dependent phagocytosis by splenic B lymphocytes. Cell Immunol 1985; 91: 520-527.
11. 11. Frolov AF, Ruban NM, Vasyurenko ZP. Fatty acid composition of lipopolysaccharides of the strains of different species of Yersinia. Z Hyg Epidemiol Microbiol Immunol 1989; 33: 55-61.
12. 12. Walker RV. Comparative physiopathology of plague endotoxin in mice, guinea-pigs and monkeys. J Infect Dis 1968; 118: 188-196.
13. 13. Gooseva IP. Liposome forms of Yersinia pestis immunogens. PhD Thesis. Russia State Antiplague Research Institute 'Microbe', Saratov, Russia. 1995.
14. 14. Westernik MAJ, Apicella MA. Anti-idiotypic antibodies as a vaccine against carbohydrate antigens. Springer Semin Immunopathol 1993; 15: 227-234.
15. 15. Chanh TC, Hewetson JF. Polyclonal anti-idiotypes induce antibody responses protective against ricin cytotoxicity. Immunology 1993; 79: 681-684.
16. 16. Cornelissen JJ, Maassen K, van Emst L et al. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice. Immunology 1993; 79: 673-680.
17. 17. Field SK, Morrison DC. An anti-idiotypic antibody which mimics the inner-core region of lipopolysaccharide protects mice against a lethal challenge with endotoxin. Infect Immun 1094; 62: 3994-3999.
18. 18. Devdariani ZL, Verenkov MS, Feodorova VA, Solodovnicov NS, Belov LG. Identification of Yersinia pestis with varied plasmid composition using monoclonal and polyclonal fluorescent immunoglobulins. FEMS Immunol Med Microbiol 1993; 6: 31-35.
19. 19. Protsenko OA, Filippov AA, Kutyrev W. [Plasmid heterogeneity in populations of Yersinia pestis strains.] Mol Gen Mikrobiol Virusol 1992; (3-4): 20-24.
20. 20. Anisimov PI, Serdobintsev LN, Ivanov IUV, Taranenko TM, Naumov AV. [Various physico-chemical properties of the Yersinia pestis capsular protein.] Mol Gen Mikrobiol Virusol 1987; (2): 24-27.
21. 21. Ouchterlony Ö. Antigen-antibody reactions in gels. Types of reactions in coordinated systems of diffusion. Acta Pathol Microbiol Scand 1953; 32: 231-240.
22. 22. Anisimov PI, Kuznetsova KA, Devdariani ZL et al. Results of research devoted to constructing of plague luminescence diagnostic anticapsular serum based on McAb against Yersinia pestis Fraction I. In: Diagnostics and prophylaxis of particularly dangerous diseases. Saratov, Russia. 1983: 3-8.
23. 23. Ashmarin IP, Vorob'ov AA. Statistical methods in microbiological research. Leningrad, State Press of Medical Literature. 1962: 10-104.
24. 24. Devdariani ZL, Feodorova VA, Solodovnikov NS et al. ELISA test system tor identification of typical and atypical plague microbe strains. Med Parasitol Parasite Dis 1997; 1: 31-34.
25. 25. Jerne NK. Towards a network theory of the immune system. Ann Immunol 1974; 125: 373-389.
26. 26. Kresina TF, Olds GR. Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen. J Clin Invest 1989; 83: 912-920.
27. 27. Li J-L, Chen J-L, Ouyang M-N et al. Immunization strategies for the production of rat monoclonal anti-idiotype antibodies. J Immunol Methods 1991; 142: 15-20.
28. 28. Grsych J-M, Rousse-Velge F, Capron A. Use of anti-idiotypic antibodies in approaches to immunoprophylaxis of schistosomiasis. In: Langone J (ed) Antibodies, antigens and molecular mimicry. San Diego, Academic Press. 1989: Methods Enzymol 178: 390-404.
29. 29. Schreiber JR, Nixon KL, Tosi MF, Pier GB, Patawaran MB. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J Immunol 1991; 146: 188-193.
30. 30. Schreiber JR. Anti-idiotype vaccines for immunity to bacterial polysaccharides: induction of functional antibodies to polysaccharide antigens of Pseudomonas aeruginosa. Springer Semin Immunopathol 1993; 15: 235-246.
31. 31. Anders EM, Kapaklis-Deliyannis GP, White DO. Induction of immune response to influenza virus with anti-idiotypic antibodies. J Virol 1989; 63: 2758-2767.
32. 32. Wake A. Genetically controlled natural resistance of mice to plague infection and its relationship to genetically controlled cell-mediated immune resistance. In: Skamene E, Kongshavn PAL, Landy M (eds) Genetic control of natural resistance to infection and malignancy. New York, Academic Press. 1980: 179-184.
33. 33. Field S, Pollack M, Morrison DC. Development of an anti-idiotype monoclonal antibody mimicking the structure of lipopolysaccharide (LPS) inner-core determinants. Microb Pathog 1993; 15: 103-120.
34. 34. Gulati S, McQuillen DP, Sharon J, Rice PA. Experimental immunization with a monoclonal anti-idiotype antibody that mimics the Neisseria gonorrhoeae lipopolysaccharide epitope 2C7. J Infect Dis 1996; 174: 1238-1248.
35. 35. Schreiber JR, Dahlhauser P. Imnumogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudnmonas aeruginosa surface polysaccharides. Infect Immun 1994; 62: 308-312.
36. 36. Nazarova LS, Taranenko TM, Devdariani ZL et al. Morphological characteristics of Yersinia pestis lipopolysaccharide influence upon the murine organism. In: Problems of particularly dangerous diseases. Saratov, Russia. 1993: 147-157.